Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tate Thigpen

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus ConferenceGavin C E Stuart, Henry Kitchener, Monica Bacon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2005
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group StudyMarcus E Randall, Virginia L Filiaci, Hyman Muss, et al.
Gynecologic Oncology|December 14, 2011
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group studyKrishnansu S Tewari, Virginia L Filiaci, Nick M Spirtos, et al.
Gynecologic Oncology|December 1, 2015
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group StudyElizabeth R Burton, Mark Brady, Howard D Homesley, et al.
Cancer|September 27, 2006
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group studyG Larry Maxwell, Chunqiao Tian, John Risinger, et al.
Gynecologic Oncology|December 14, 2004
Role of pegylated liposomal doxorubicin in ovarian cancerJ Tate Thigpen, Carol A Aghajanian, David S Alberts, et al.
Gynecologic Oncology|February 19, 2011
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group studyJohn Farley, Michael W Sill, Michael Birrer, et al.
Cancer|November 20, 2009
Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group StudyJohn H Farley, Chunqiao Tian, G Scott Rose, et al.
Journal of the National Cancer Institute|March 18, 2004
Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)Gordon J S Rustin, Michael Quinn, Tate Thigpen, et al.
Gynecologic Oncology|October 24, 2007
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public WorkshopRobert C Bast, J Tate Thigpen, Susan G Arbuck, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus ConferenceGavin C E Stuart, Henry Kitchener, Monica Bacon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2005
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group StudyMarcus E Randall, Virginia L Filiaci, Hyman Muss, et al.
Gynecologic Oncology|December 14, 2011
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group studyKrishnansu S Tewari, Virginia L Filiaci, Nick M Spirtos, et al.
Gynecologic Oncology|December 1, 2015
A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group StudyElizabeth R Burton, Mark Brady, Howard D Homesley, et al.
Cancer|September 27, 2006
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group studyG Larry Maxwell, Chunqiao Tian, John Risinger, et al.
Gynecologic Oncology|December 14, 2004
Role of pegylated liposomal doxorubicin in ovarian cancerJ Tate Thigpen, Carol A Aghajanian, David S Alberts, et al.
Gynecologic Oncology|February 19, 2011
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group studyJohn Farley, Michael W Sill, Michael Birrer, et al.
Cancer|November 20, 2009
Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group StudyJohn H Farley, Chunqiao Tian, G Scott Rose, et al.
Journal of the National Cancer Institute|March 18, 2004
Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)Gordon J S Rustin, Michael Quinn, Tate Thigpen, et al.
Gynecologic Oncology|October 24, 2007
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public WorkshopRobert C Bast, J Tate Thigpen, Susan G Arbuck, et al.
Pageof 4